[United States] was Nymox Pharmaceutical’s largest region in fiscal 2020, bringing in $3.00K of $5.00K (60%).
| Geography | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 |
|---|---|---|---|---|---|---|
| Europe | $21.00K | $22.00K | $24.00K | $2.00K | ||
| [United States] | — | $276.00K | $91.00K | $3.00K | ||
| United States | $197.00K | — | — | — | ||
| Canada | $5.00K | $1.00K | $1.00K | — | ||
| Total | $223.00K | $299.00K | $116.00K | $5.00K |
Nymox Pharmaceutical brought in $5.00K from its two regions in fiscal 2020, the year ended December 31, 2020. Nymox Pharmaceutical regrouped these regions after fiscal 2019, so the total does not compare directly with that year's $116.00K. [United States] was the largest at $3.00K (60.0%), ahead of Europe at $2.00K (40.0%).
Compared with fiscal 2019, Europe fell 91.7% to $2.00K and [United States] fell 96.7% to $3.00K.
Nymox Pharmaceutical began breaking out [United States] in fiscal 2018, when it brought in $276.00K. Nymox Pharmaceutical stopped reporting United States ($197.00K in fiscal 2017) and Canada ($1.00K in fiscal 2019) as separate regions.
Nymox Pharmaceutical (NYMXF) reports its revenue by geography. In fiscal 2020, [United States] was its largest region, bringing in $3.00K (60.0% of the total), followed by Europe at $2.00K (40.0%).
[United States] was Nymox Pharmaceutical's largest region in fiscal 2020, bringing in $3.00K, or 60.0% of the $5.00K total across its two regions.
Every figure comes from Nymox Pharmaceutical's annual financial filings, as reported. Each line keeps the name Nymox Pharmaceutical gives it, and years follow its fiscal calendar.
Nymox Pharmaceutical's revenue by geography goes back to fiscal 2015, with figures through fiscal 2020. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.